CHAPTERS Group AG · ISIN: DE0006618309 · EQS - Company News

Annual Report for the 2023 financial year published

Today, CHAPTERS Group AG published its Annual Report for the 2023 financial year. The entire Annual Report 2023 is available at the following Website: Annual Report 2023 27.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

XETR:CHG Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News CHAPTERS Group AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (9)
Short Selling (DE) (0)
Short Selling (UK) (0)
27 May 2024 06:05PM
Annual Report for the 2023 financial year published
DE0006618309
Today, CHAPTERS Group AG published its Annual Report for the 2023 financial year. The entire Annual Report 2023 is available at the following Website: Annual Report 2023 27.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
CHAPTERS Group AG
About the publication
26 March 2024 08:00AM
Buyback offer for up to EUR 9 million nominal amount of the 2020 bond
DE0006618309
In May 2023, the company placed the bearer bonds held by the company itself from the 2020 bond (ISIN: DE000A254TL0) and committed to an anchor investor to conduct one or more public buyback offers if certain conditions are met. In the meantime, the company has received funds from the repayment of shareholder loans issued in previous years. The Mana...
CHAPTERS Group AG
About the publication
05 March 2024 08:05AM
CHAPTERS Group AG finishes successful 2023 financial year; Strong momentum continues in 2024
DE0006618309
2023 was a transformative year for CHAPTERS Group AG as the group made significant progress on several strategic initiatives in building the home for mission-critical businesses in Europe. In 2023, 18 operating companies joined the group. mlog, a new VMS platform focusing on the French market was launched and CHAPTERS increased its ownership posit...
CHAPTERS Group AG
About the publication
31 January 2024 02:00PM
Extension of Marlene Carl's Management Board contract and Jan-Hendrik Mohr's parental leave
DE0006618309
On January 11, 2024, the company's Supervisory Board unanimously extended the contract of CFO Marlene Carl until December 31, 2028. Supervisory Board Chairman Dr. Mathias Saggau commented: "Marlene has played a decisive role in shaping the professionalization and further development of the group in recent years. We are delighted that she will rem...
CHAPTERS Group AG
About the publication
25 January 2024 08:07PM
Capital Increase against contribution in kind from Authorized Capital resolved
DE0006618309
As announced in the ad-hoc release of January 25, 2024, the Management Board (with the approval of the Supervisory Board) of CHAPTERS Group AG (ISIN: DE0006618309) resolved a capital increase against contribution in kind from authorized capital with the exclusion of subscription rights by issuing new shares in the amount of approx. 7.7% of the shar...
CHAPTERS Group AG
About the publication
25 January 2024 08:01PM
Capital Increase against contribution in kind from Authorized Capital resolved
DE0006618309
Today, the Management Board (with the approval of the Supervisory Board) of CHAPTERS Group AG (ISIN: DE0006618309) resolved a capital increase from authorized capital with the exclusion of subscription rights by issuing 1,398,513 new shares against contributions in kind and making partial use of EUR 1,398,513.00 of the existing authorized capital o...
CHAPTERS Group AG
About the publication
24 November 2023 09:13AM
Raising of Additional Equity to Drive Acceleration of Growth
DE0006618309
As announced in the ad-hoc release of 24 Nov 2023, CHAPTERS Group AG successfully completed a capital increase. The company raised approx. EUR 29 million in equity by issuing 1,649,926 new shares at EUR 17.61 per share. Jan-Hendrik Mohr, CEO of CHAPTERS Group AG commented: „Growth keeps on accelerating. In this placing, we enjoyed the support of...
CHAPTERS Group AG
About the publication
24 November 2023 09:00AM
Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 23, 2023
DE0006618309
The private placement of the capital increase resolved on November 23, 2023 excluding subscription rights by issuing new shares was successfully completed in the amount of 1.649.926 new shares. The subscription price was EUR 17.61 per new share, resulting in gross proceeds of approx. EUR 29 million. Subject to the registration in the Commercial Re...
CHAPTERS Group AG
About the publication
23 November 2023 06:11PM
Capital Increase from Authorized Capital Resolved
DE0006618309
Today, the Management Board (with the approval of the Supervisory Board) of CHAPTERS Group AG (ISIN: DE0006618309) resolved a capital increase from authorized capital with the exclusion of subscription rights by issuing up to 10% of its registered share capital of EUR 16.499.266,00. The new shares will be offered exclusively to professional invest...
CHAPTERS Group AG
About the publication
29 September 2023 01:12PM
2023 Interim Report Shows Strong Growth in the First Half of the Year
DE0006618309
Today, the company published its 2023 half-year interim report: With 31 operating companies at June 30, the group achieved Euro 43.7m revenue – an increase of +77% to the comparable period in 2022. In the first half of 2023, the EBITDA (adjusted) of operating companies of Euro 11.1m increased 61% over the same period in 2022. Very strong growth i...
CHAPTERS Group AG
About the publication
07 September 2023 06:56PM
Management buy-out of the property services group of NGC Nachfolgekapital GmbH
DE0006618309
Today, CHAPTERS Group AG announces the successful spin-off by means of a 100% management buy-out of ARUDI GmbH ("ARUDI") and its operating subsidiaries gelford GmbH Gebäudereinigung und Dienstleistungen, Diamant Gebäudereinigungsdienst GmbH, Calmund & Riemer GmbH, and Bastex Schädlingsbekämpfung & Hygienetechnik GmbH, from its subsidiary NG...
CHAPTERS Group AG
About the publication
07 September 2023 06:46PM
Management buy-out of the property services group of NGC Nachfolgekapital GmbH
DE0006618309
Today, NGC Nachfolgekapital GmbH, a 80% subsidiary of CHAPTERS Group AG, entered into an agreement to spin-off ARUDI GmbH ("ARUDI") and its operating subsidiaries gelford GmbH Gebäudereinigung und Dienstleistungen, Diamant Gebäudereinigungsdienst GmbH, Calmund & Riemer GmbH, and Bastex Schädlingsbekämpfung & Hygienetechnik GmbH, from its su...
CHAPTERS Group AG
About the publication
01 August 2023 10:22AM
Officially Starting the Next CHAPTER
DE0006618309
Last week, the commercial register in Hamburg registered the renaming of the company to CHAPTERS Group AG as approved by the shareholders at our AGM in June 2023. Today, our new website www.chaptersgroup.com went live. We chose this name to express our conviction that we will embark on several new and successful chapters in the years ahead. To ac...
CHAPTERS Group AG
About the publication
01 August 2023 10:22AM
Officially Starting the Next CHAPTER
DE0006618309
Last week, the commercial register in Hamburg registered the renaming of the company to CHAPTERS Group AG as approved by the shareholders at our AGM in June 2023. Today, our new website www.chaptersgroup.com went live. We chose this name to express our conviction that we will embark on several new and successful chapters in the years ahead. To ac...
CHAPTERS Group AG
About the publication
26 May 2023 08:55AM
Expansion of Capital Base to Accelerate Growth
DE0006618309
As announced in the ad-hoc release of May 26, 2023, MEDIQON Group AG has successfully completed a share capital increase and a bond placing of the 2020 perpetual bond. Both transactions will raise circa EUR 16 million in additional funds for the Group. These proceeds will be invested to further accelerate the Group’s growth. Furthermore, the compa...
MEDIQON Group AG
About the publication
26 May 2023 08:55AM
MEDIQON Group AG: Expansion of Capital Base to Accelerate Growth
DE0006618309
As announced in the ad-hoc release of May 26, 2023, MEDIQON Group AG has successfully completed a share capital increase and a bond placing of the 2020 perpetual bond. Both transactions will raise circa EUR 16 million in additional funds for the Group. These proceeds will be invested to further accelerate the Group’s growth. Furthermore, the compa...
MEDIQON Group AG
About the publication
24 May 2023 12:29PM
MEDIQON Group AG: 2022 Annual Report - Strong Operating Performance and Continued Success with Acquisitions - Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of Growth
DE0006618309
MEDIQON Group AG: 2022 Annual Report - Strong Operating Performance and Continued Success with Acquisitions - Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of GrowthLast week, the company published its 2022 annual report. With 26 operating companies at year end, the group achieved EUR 67.1m of revenue in 2022 and EUR 16....
MEDIQON Group AG
About the publication
24 May 2023 12:29PM
2022 Annual Report - Strong Operating Performance and Continued Success with Acquisitions - Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of Growth
DE0006618309
MEDIQON Group AG: 2022 Annual Report - Strong Operating Performance and Continued Success with Acquisitions - Renaming and New Board Director Proposed at AGM to Embark on Next Chapter of GrowthLast week, the company published its 2022 annual report. With 26 operating companies at year end, the group achieved EUR 67.1m of revenue in 2022 and EUR 16....
MEDIQON Group AG
About the publication
17 May 2023 11:40AM
Annual Report for the 2022 financial year published
DE0006618309
Today, MEDIQON Group AG published its Annual Report for the 2022 financial year. The entire Annual Report 2022 is available at the following Website:https://www.mediqon-group.de/veroeffentlichungen/annual-reports/   17.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
MEDIQON Group AG
About the publication
17 May 2023 11:40AM
MEDIQON Group AG: Annual Report for the 2022 financial year published
DE0006618309
Today, MEDIQON Group AG published its Annual Report for the 2022 financial year. The entire Annual Report 2022 is available at the following Website:https://www.mediqon-group.de/veroeffentlichungen/annual-reports/   17.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
MEDIQON Group AG
About the publication
14 April 2023 07:45AM
MEDIQON Group AG: Group growth continued again in the 2022 financial year and a successful start to the 2023 financial year
DE0006618309
In the 2022 fiscal year, the growth of the group continued again. The platforms belonging to the group have acquired majority stakes in eight additional operating companies. At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings. Furthermore, the company’s equity base doubled in the 2022 fi...
MEDIQON Group AG
About the publication
14 April 2023 07:45AM
Group growth continued again in the 2022 financial year and a successful start to the 2023 financial year
DE0006618309
In the 2022 fiscal year, the growth of the group continued again. The platforms belonging to the group have acquired majority stakes in eight additional operating companies. At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings. Furthermore, the company’s equity base doubled in the 2022 fi...
MEDIQON Group AG
About the publication
16 February 2023 09:58AM
Executive Board contract of Jan-Hendrik Mohr extended
DE0006618309
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended Yesterday, the company's Supervisory Board unanimously extended the contract of CEO Jan-Hendrik Mohr until December 31, 2027. Supervisory Board Chairman Dr. Mathias Saggau commented: "We are happy that Jan wants to continue to drive the growth of MEDIQON Group AG and committed ...
MEDIQON Group AG
About the publication
16 February 2023 09:58AM
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended
DE0006618309
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended Yesterday, the company's Supervisory Board unanimously extended the contract of CEO Jan-Hendrik Mohr until December 31, 2027. Supervisory Board Chairman Dr. Mathias Saggau commented: "We are happy that Jan wants to continue to drive the growth of MEDIQON Group AG and committed ...
MEDIQON Group AG
About the publication
13 December 2022 10:02AM
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
DE0006618309
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase. The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors. ...
MEDIQON Group AG
About the publication
13 December 2022 10:02AM
Expansion of Equity Base to Accelerate Growth
DE0006618309
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase. The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors. ...
MEDIQON Group AG
About the publication
13 December 2022 08:34AM
Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on December 12, 2022
DE0006618309
The private placement of the capital increase resolved on December 12, 2022, excluding subscription rights by issuing new shares was successfully completed in the amount of 1,067,267  new shares. The increase is equivalent to c. 7.1% of the company’s existing share capital. The subscription price was EUR 14.50 per new share, resulting in gross proc...
MEDIQON Group AG
About the publication
13 December 2022 08:34AM
MEDIQON Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on December 12, 2022
DE0006618309
The private placement of the capital increase resolved on December 12, 2022, excluding subscription rights by issuing new shares was successfully completed in the amount of 1,067,267  new shares. The increase is equivalent to c. 7.1% of the company’s existing share capital. The subscription price was EUR 14.50 per new share, resulting in gross proc...
MEDIQON Group AG
About the publication
12 December 2022 06:06PM
MEDIQON Group AG: Capital Increase from Authorized Capital Resolved
DE0006618309
Today, the Management Board (with the approval of the Supervisory Board) of MEDIQON Group AG (ISIN: DE0006618309) resolved a capital increase from authorized capital with the exclusion of subscription rights by issuing up to 10% of its registered share capital of EUR 14,999,333.00. The Company expects to raise EUR 10 to 20 million. The new shares w...
MEDIQON Group AG
About the publication
12 December 2022 06:06PM
Capital Increase from Authorized Capital Resolved
DE0006618309
Today, the Management Board (with the approval of the Supervisory Board) of MEDIQON Group AG (ISIN: DE0006618309) resolved a capital increase from authorized capital with the exclusion of subscription rights by issuing up to 10% of its registered share capital of EUR 14,999,333.00. The Company expects to raise EUR 10 to 20 million. The new shares w...
MEDIQON Group AG
About the publication
30 September 2022 12:25PM
MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022
DE0006618309
MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022 Today, MEDIQON Group AG published its Interim Report 2022. In the first half of 2022, 3 additional operating companies became part of the group. As of June 30, 2022, a total of 22 operating companies belong to the group, two of which are minority hol...
MEDIQON Group AG
About the publication
30 September 2022 12:25PM
Interim Report 2022 – Positive development of the group in the first half of 2022
DE0006618309
MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022 Today, MEDIQON Group AG published its Interim Report 2022. In the first half of 2022, 3 additional operating companies became part of the group. As of June 30, 2022, a total of 22 operating companies belong to the group, two of which are minority hol...
MEDIQON Group AG
About the publication
24 May 2022 03:56PM
MEDIQON Group AG: Annual Report 2021 published – Group growth continued successfully in the 2021 fiscal year
DE0006618309
MEDIQON Group AG: Annual Report 2021 published – Group growth continued successfully in the 2021 fiscal year Today, MEDIQON Group AG published its Annual report 2021. The group’s growth continued successfully in the financial year. In 2021, 10 additional operating companies became part of the group. At the end of the fiscal year, 20 operating com...
MEDIQON Group AG
About the publication
13 April 2022 05:07PM
MEDIQON Group AG: Investor Base strengthened with 2022 Rights Issue
DE0006618309
MEDIQON Group AG: Investor Base strengthened with 2022 Rights Issue Further to the 04/07/2022 ad-hoc release, MEDIQON Group AG today announces the successful placing of the 2022 rights issue. The company raised EUR 41.6m by issuing 3,999,820 new shares. The rights issue was significantly oversubscribed. Sator Grove Holdings LLC and Mitch Rales, ...
MEDIQON Group AG
About the publication
07 April 2022 07:33PM
MEDIQON Group AG: Placement of the capital increase with subscription rights successfully completed
DE0006618309
MEDIQON Group AG has successfully placed all new shares from the capital increase with subscription rights resolved on March 15, 2022. The capital increase is subject to the entry in the commercial register. The share capital of the company will increase from EUR 10,999,513.00 to EUR 14,999,333.00 by issuing to 3,999,820 new shares against cash co...
MEDIQON Group AG
About the publication
15 March 2022 05:50PM
MEDIQON Group AG: Capital Increase via subscription rights issue resolved
DE0006618309
MEDIQON Group AG: Capital Increase via subscription rights issue resolved The Management Board of MEDIQON Group AG (ISIN: DE0006618309) today resolved, with the approval of the supervisory board, to increase the share capital of the company from 10,999,513.00 to EUR 14,999,333.00 by issuing up to 3,999,820 new shares against cash distribution wit...
MEDIQON Group AG
About the publication
14 March 2022 07:03PM
MEDIQON Group AG: NGC Nachfolgekapital GmbH, a subsidiary of MEDIQON Group AG, entered into a transaction agreement in relation to its subsidiary vetera GmbH
DE0006618309
NGC Nachfolgekapital GmbH, a subsidiary of MEDIQON Group AG, entered into a transaction agreement in relation to its subsidiary vetera GmbH Today, Nordhealth A/S and NGC Nachfolgekapital GmbH, an 80% subsidiary of MEDIQON Group AG agreed that vetera GmbH, an 80% subsidiary of NGC Nachfolgekapital GmbH will become part of the Portfolio of Practice...
MEDIQON Group AG
About the publication
24 February 2022 08:30AM
MEDIQON Group AG: Group growth continued successfully in the 2021 fiscal year
DE0006618309
MEDIQON Group AG: Group growth continued successfully in the 2021 fiscal year MEDIQON Group AG once again grew strongly in the 2021 fiscal year. At the end of 2021, a total of 20 operating companies belong to the group - two of them as minority interests. The gross investment volume as part of the acquisition of majority holdings and the resultin...
MEDIQON Group AG
About the publication
04 November 2021 06:33PM
MEDIQON Group AG: Conclusion of an Investment Agreement
DE0006618309
MEDIQON Group AG: Conclusion of an Investment Agreement As announced in the 04/11/2021, 18.20 ad-hoc notice, management and supervisory boards of MEDIQON Group AG have resolved on a 10% cash capital increase from authorized capital (up to 999,955 shares) today. In addition, it was decided to start preparations of an additional capital increase via...
MEDIQON Group AG
About the publication
More CHAPTERS Group AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 9 27th November 2023 Carl, Marlene DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN